Recently Viewed
Clear All
Bidding Date
20-Dec-2024 to
24-Dec-2024
Issue Size
₹132.11 Cr
Price Band
₹372 to ₹391
Allotment date
26-Dec-2024
Listing date
30-Dec-2024
Lot size
38
No. of shares
33,78,772
Fresh issue/OFS
₹50 Cr/₹82.11 Cr
The core business of Senores Pharmaceuticals revolves around the identification, development, and commercialization of specialty, underpenetrated, and complex pharmaceutical products. The company primarily operates in regulated markets (US, Canada, UK), where it focuses on products that require significant regulatory compliance. It also caters to emerging markets through partnerships, distributors, and direct sales under various business models, such as distributor, P2P, and CDMO. The company manufactures and markets critical care injectables and Active Pharmaceutical Ingredients (APIs), further diversifying its product offerings. It operates through strategic partnerships with other pharmaceutical companies, including Prasco LLC, Lannett Company Inc., Jubilant Cadista Pharmaceuticals Inc., among others, to market products across different therapeutic areas.
Read our in-depth analysis of the Senores Pharmaceuticals Ltd IPO Here 
Category
Status
QIBs
94.7x
NIIs
96.1x
Retail
89.1x
Others
19.9x
Total
93.4x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Highness Microelectronics | 114 - 120 | 24-Mar-2026 to 27-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
| Powerica | 375 - 395 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Senores Pharmaceuticals is ₹132.11 Cr.
Senores Pharmaceuticals falls into Pharmaceuticals industry.
The Senores Pharmaceuticals IPO will be listed on both NSE and BSE.
The open and close dates for the Senores Pharmaceuticals are 20-Dec-2024 & 24-Dec-2024.
The price band for the Senores Pharmaceuticals ipo is ₹372 to ₹391
The listing date of Senores Pharmaceuticals IPO is 30-Dec-2024.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Senores Pharmaceuticals total subscription ratio is 93.4X.
Key financial of the Senores Pharmaceuticals are:
| Senores Pharmaceuticals | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 214.52 | 35.34 | 14.17 |
| EBIT (₹ Cr) | 31.57 | 10.89 | 1.25 |
| Proft after Tax (₹ Cr) | 32.71 | 8.43 | 0.99 |
| Debt (₹ Cr) | 248.39 | 60.76 | 14.21 |
| Net Worth (₹ Cr) | 231.71 | 45.5 | 36.59 |
| RoE (%) | 14.12 | 18.53 | 2.71 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
